Q2 2025 Bonesupport Holding AB Earnings Call Transcript
Key Points
- Bonesupport Holding AB (BOEUF) reported a strong Q2 2025 with net sales of SEK284 million, reflecting a 29% growth compared to the previous year and 40% growth in constant currency.
- The company achieved a significant milestone with CERAMENT G sales in the US reaching $18.3 million, marking an 84% growth in constant currency.
- The launch momentum for CERAMENT G in the US is exceptionally strong, with accumulated sales reaching SEK1 billion since its launch in Q4 2022.
- The company is expanding its market presence with the planned launch of CERAMENT BVF in the spine segment in December 2025, targeting both the US and Canadian markets.
- Bonesupport Holding AB (BOEUF) maintains a strong gross margin of around 95%, demonstrating effective cost management and operational efficiency.
- The company faced a negative impact from currency fluctuations, with the US dollar's depreciation against the Swedish krona affecting reported sales and operating results.
- Sales growth in Europe was modest at 4% year-over-year, impacted by fewer surgery days and ongoing hospital reforms in Germany.
- The uncertainty regarding potential tariffs between the EU and the US poses a risk, although the company expects the impact to be minimal.
- The submission for CERAMENT V to the FDA has encountered questions and requests for clarification, potentially delaying market authorization.
- The ongoing hospital reform in Germany has led to disruptions, with some hospitals reverting to autograft use, impacting sales of synthetic bone grafts.
Welcome to Bonesupport Q2 2025. (Operator Instructions)
Now I will hand the conference over to CEO, Emil Billback; and CFO, Hakan Johansson. Please go ahead.
Thank you, operator. Good morning, and welcome, everyone, to Bonesupport's Quarter 22025 results call. I am Emil Billback, the CEO and I'm making this broadcast, as always, together with Hakan Johansson, our CFO. So over the next 25 minutes, we will guide you through the presentation of the second quarter results, and then we will open up the line for question and answers.
So if we go to the next slide, we will see the normal and usual disclaimers. And it's like to draw your attention to those in case there are any forward-looking statements we might make today. We'll go to next slide, slide 3, and we'll start the presentation. So quarter 2 2025 was another strong quarter for Bonesupport with solid execution across the business.
Net sales came in at SEK284 million, which corresponds to a growth of 29% versus
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
